Market Place
Sourcing Support
Jacobio Hits 71% ORR, Paves Way for First SHP-2 NSCLC Therapy
04 Dec 2025 //
INDPHARMAPOST
Registrational Clinical Data of Glecirasib was Published
06 Jan 2025 //
PR NEWSWIRE
Jacobio Out-Licenses KRAS And SHP2 Inhibitors To Allist In China
31 Aug 2024 //
PR NEWSWIRE
Jacobio plans bid for China’s KRAS market with safety edge
02 May 2024 //
PHARMAPHORUM
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.